Peripheral arterial disease: An underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients

European Journal of Preventive Cardiology

Volumn 15, Issue 3, 2008, Pages 270-277

  Castagna, Olivier ^a,b,d   Boussuges, Alain ^a   Nussbaum, Eric ^c   Marqueste, Louis ^d   Brisswalter, Jeanick ^b  

^a I M N S S A B P 610 83800 Toulon Armées   (France)

^b UNIVERSITÉ DE TOULON   (France)

^c Centre Rhone Azur   (Sweden)

^d General Hospital CHITS   (France)

Author keywords

ankle brachial index; cardiovascular risk factor; chronic obstructive pulmonary disease; exercise tolerance; peripheral arterial disease; pulse wave velocity; tobacco

Indexed keywords

AGED; ANAMNESIS; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PERFUSION PRESSURE; PHYSICAL CAPACITY; PREVALENCE; PRIORITY JOURNAL; CASE CONTROL STUDY; HOSPITALIZATION; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; SMOKING;

AGED; CASE-CONTROL STUDIES; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 56149114118     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3282f009a9     Document Type: Article

References (22)

1. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999; 159: S1–S40.
2. Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective. Respirology 2005; 10: 9–17.
3. Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2: 8–11.
4. Zureik M, Benetos A, Neukirch C, Courbon D, Bean K, Thomas F et al. Reduced pulmonary function is associated with central arterial stiffness in men. Am J Respir Crit Care Med 2001; 164: 2181–2185.
5. Hagg U, Wandt B, Bergstrom G, Volkmann R, Gan LM. Physical exercise capacity is associated with coronary and peripheral vascular function in healthy young adults. Am J Physiol Heart Circ Physiol 2005; 289: H1627–H1634.
6. The GOLD Workshop Panel. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Workshop Report. Bethesda, Maryland: National Heart, Lung, and Blood Institute; NIH Publication No. 2701. 2001.
7. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. The American review of respiratory disease; 1991: 1202–1218.
8. Standardized Lung Function Testing. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 1–100.
9. Enright PL. The six-minute walk test. Respiratory Care 2003; 48: 783–785.
10. Group WS. Diabetes mellitus. World Health Organ Tech Rep Ser 1985; 727: 9–20.
11. Rogoza AN, Pavlova TS, Sergeeva MV. Validation of A&D UA-767 device for the self-measurement of blood pressure. Blood Press Monit 2000; 5: 227–231.
12. Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996; 94: 3026–3049.
13. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485–490.
14. Schols A. Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease. Proc Nutr Soc 2003; 62: 783–791.
15. Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22: 809–814.
16. Fiaccadori E, Coffrini E, Fracchia C, Rampulla C, Montagna T, Borghetti A. Hypophosphatemia and phosphorus depletion in respiratory and peripheral muscles of patients with respiratory failure due to COPD. Chest 1994; 105: 1392–1398.
17. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990; 81: 518–527.
18. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996; 348: 567–572.
19. Selvin E, Erlinger T. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation 2004; 110: 738–743.
20. Emanuele M, Buchanan B, Abraira C. Elevated leg systolic pressures and arterial calcification in diabetic occlusive vascular disease. Diabetes Care 1981; 4: 289–292.
21. Walters D, Gatling W, Mullee M, Hill R. The prevalence, detection, and epidemiological correlates of peripheral arterial disease: a comparison of diabetic and non-diabetic subjects in an English community. Diabet Med 1992; 9: 710–715.
22. Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 2005; 26: 703–719.